• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

From Fragmented Data to Actionable Insights: Predicting HCC in Fontan Patients-A Call for Collaboration.

作者信息

Hilscher Moira, Venkatesh Sudhakar

机构信息

, Rochester, USA.

Division of Gastroenterology and Hepatology, Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA.

出版信息

Dig Dis Sci. 2024 Dec;69(12):4333-4335. doi: 10.1007/s10620-024-08678-1. Epub 2024 Oct 28.

DOI:10.1007/s10620-024-08678-1
PMID:39466492
Abstract
摘要

相似文献

1
From Fragmented Data to Actionable Insights: Predicting HCC in Fontan Patients-A Call for Collaboration.从碎片化数据到可操作的见解：预测Fontan患者的肝癌——呼吁合作
Dig Dis Sci. 2024 Dec;69(12):4333-4335. doi: 10.1007/s10620-024-08678-1. Epub 2024 Oct 28.
2
Liver Cirrhosis and/or Hepatocellular Carcinoma Occurring Late After the Fontan Procedure　- A Nationwide Survey in Japan.《Fontan 手术后晚期发生的肝硬化和/或肝细胞癌：日本全国性调查》
Circ J. 2018 Mar 23;82(4):1155-1160. doi: 10.1253/circj.CJ-17-1053. Epub 2018 Feb 14.
3
Hepatocellular carcinoma and the Fontan circulation: Clinical presentation and outcomes.肝细胞癌与 Fontan 循环：临床表现与结局。
Int J Cardiol. 2021 Jan 1;322:142-148. doi: 10.1016/j.ijcard.2020.08.057. Epub 2020 Aug 21.
4
The absence of warfarin treatment and situs inversus are associated with the occurrence of hepatocellular carcinoma after Fontan surgery.法乐四联症根治术后发生肝细胞癌与华法林治疗的缺失和内脏反位相关。
J Gastroenterol. 2022 Feb;57(2):111-119. doi: 10.1007/s00535-021-01842-8. Epub 2022 Jan 22.
5
Risk of Liver Cirrhosis and Hepatocellular Carcinoma after Fontan Operation: A Need for Surveillance.Fontan手术后肝硬化和肝细胞癌的风险：监测的必要性。
Cancers (Basel). 2020 Jul 6;12(7):1805. doi: 10.3390/cancers12071805.
6
A Meta-Analysis of Cumulative Incidence of Hepatocellular Carcinoma After the Fontan Operation.Fontan 术后肝细胞癌累积发生率的荟萃分析。
Dig Dis Sci. 2024 Dec;69(12):4467-4475. doi: 10.1007/s10620-024-08470-1. Epub 2024 Jun 13.
7
Meta-analysis: Incidence of cirrhosis and hepatocellular carcinoma in patients with Fontan palliation.荟萃分析：接受Fontan姑息治疗患者的肝硬化和肝细胞癌发病率
Aliment Pharmacol Ther. 2024 May;59(9):1020-1032. doi: 10.1111/apt.17952. Epub 2024 Mar 18.
8
Characteristics of hepatocellular carcinoma arising from Fontan-associated liver disease.源自Fontan相关肝病的肝细胞癌的特征
Hepatol Res. 2020 Jul;50(7):853-862. doi: 10.1111/hepr.13500. Epub 2020 Apr 30.
9
Robot-assisted laparoscopic hepatectomy for hepatocellular carcinoma with Fontan-associated liver disease: a world-first case report.机器人辅助腹腔镜肝切除术治疗伴有Fontan相关肝病的肝细胞癌：世界首例病例报告
Surg Case Rep. 2024 Sep 9;10(1):210. doi: 10.1186/s40792-024-02014-5.
10
Detection of hepatocellular carcinoma during Fontan-associated liver disease follow-up: a report of three cases.法桐相关肝病随访中肝细胞癌的检测：三例报告。
Clin J Gastroenterol. 2024 Feb;17(1):148-154. doi: 10.1007/s12328-023-01892-w. Epub 2023 Nov 30.

本文引用的文献

1
A Meta-Analysis of Cumulative Incidence of Hepatocellular Carcinoma After the Fontan Operation.Fontan 术后肝细胞癌累积发生率的荟萃分析。
Dig Dis Sci. 2024 Dec;69(12):4467-4475. doi: 10.1007/s10620-024-08470-1. Epub 2024 Jun 13.
2
Clinical Outcomes of Adult Fontan-Associated Liver Disease and Combined Heart-Liver Transplantation.成人 Fontan 相关肝病的临床结果和心脏-肝脏联合移植。
J Am Coll Cardiol. 2023 Jun 6;81(22):2149-2160. doi: 10.1016/j.jacc.2023.03.421.
3
Fontan-associated liver disease.Fontan相关肝病
Hepatology. 2022 May;75(5):1300-1321. doi: 10.1002/hep.32406. Epub 2022 Mar 15.
4
Incidence and Expected Probability of Liver Cirrhosis and Hepatocellular Carcinoma After Fontan Operation.Fontan手术后肝硬化和肝细胞癌的发病率及预期概率
Circulation. 2021 Dec 21;144(25):2043-2045. doi: 10.1161/CIRCULATIONAHA.121.056870. Epub 2021 Dec 20.
5
Hepatocellular carcinoma and the Fontan circulation: Clinical presentation and outcomes.肝细胞癌与 Fontan 循环：临床表现与结局。
Int J Cardiol. 2021 Jan 1;322:142-148. doi: 10.1016/j.ijcard.2020.08.057. Epub 2020 Aug 21.
6
Cost-Effectiveness of Hepatocellular Carcinoma Surveillance: An Assessment of Benefits and Harms.肝癌监测的成本效益：效益和危害评估。
Am J Gastroenterol. 2020 Oct;115(10):1642-1649. doi: 10.14309/ajg.0000000000000715.
7
Platelet GPIbα is a mediator and potential interventional target for NASH and subsequent liver cancer.血小板 GPIbα 是 NASH 及其后续肝癌的介质和潜在的干预靶点。
Nat Med. 2019 Apr;25(4):641-655. doi: 10.1038/s41591-019-0379-5. Epub 2019 Apr 1.
8
Hepatocellular Carcinoma After Fontan Operation: Multicenter Case Series.Fontan手术后的肝细胞癌：多中心病例系列
Circulation. 2018 Aug 14;138(7):746-748. doi: 10.1161/CIRCULATIONAHA.117.032717.
9
Benign nodules in post-Fontan livers can show imaging features considered diagnostic for hepatocellular carcinoma.法乐四联症根治术后肝脏良性结节可出现影像学表现，这些表现被认为对肝细胞癌具有诊断意义。
Abdom Radiol (NY). 2017 Nov;42(11):2623-2631. doi: 10.1007/s00261-017-1181-9.
10
The Fontan epidemic: Population projections from the Australia and New Zealand Fontan Registry.Fontan手术流行情况：来自澳大利亚和新西兰Fontan注册中心的人口预测
Int J Cardiol. 2016 Sep 15;219:14-9. doi: 10.1016/j.ijcard.2016.05.035. Epub 2016 May 14.